HYPERGLYKOSILIERTE BINDENDE POLYPEPTIDE

European patent · EP2970469 · In force

Register entry

Publication number
EP2970469
Application number
EP14714881
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 10, 2014
Published
Jan 20, 2016
Granted
Oct 3, 2018
Protection ends at the latest
Mar 9, 2034
Next annual fee due
Mar 31, 2027
IPC classes
C07K 16/28 (2006.01)
Priority
US 201361776724 P 11.03.2013
US 201361776715 P 11.03.2013
US 201361776710 P 11.03.2013
PCT application
PCT/US2014/022623 10.03.2014
PCT publication
WO2014/164503 09.10.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Oct 3, 2018

    Granted

    Published in Swissreg on 03.10.2018

Parties

Holder

Genzyme Corporation

50 Binney Street, Cambridge, MA 02142, US

Inventor

GIANOLIO, Diego

Bridgewater, NJ 08807, US

QIU, Huawei

Bridgewater, NJ 08807, US

CHEN, Bo

Bridgewater, NJ 08807, US

DHAL, Pradeep

Bridgewater, NJ 08807, US

PAN, Clark

Bridgewater, NJ 08807, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.